Company Filing History:
1 out of 622 
1 out of 16 Years Active: 2021
Title: Yen-Chung Lai: Innovator in Anti-Dengue Virus Antibodies
Introduction
Yen-Chung Lai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibodies targeting the dengue virus. His innovative work has the potential to impact public health positively.
Latest Patents
Yen-Chung Lai holds a patent for an anti-dengue virus antibody, along with a pharmaceutical composition comprising the same and its various uses. The patent discloses an anti-DENV antibody that includes a heavy chain variable region and a light chain variable region. Specifically, the heavy chain variable region comprises amino acid sequences of SEQ ID NOs: 1-3, while the light chain variable region comprises amino acid sequences of SEQ ID NOs: 5-7. This invention represents a significant advancement in the fight against dengue fever.
Career Highlights
Throughout his career, Yen-Chung Lai has worked with esteemed institutions, including National Cheng Kung University and DCB-USA LLC. His experience in these organizations has allowed him to develop his expertise in antibody research and pharmaceutical applications.
Collaborations
Yen-Chung Lai has collaborated with several professionals in his field, including Trai-Ming Yeh and Yung-Chun Chuang. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Yen-Chung Lai's work in developing an anti-dengue virus antibody showcases his innovative spirit and dedication to improving health outcomes. His contributions to the pharmaceutical field are noteworthy and have the potential to make a significant impact on public health.